Overview of Vaccination in Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 13, Issue 3, 2006, Pages 209-214

  Kausz, Annamaria T ^a   Gilbertson, David T ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Chronic kidney disease; End stage renal disease; Epidemiology; Infection; Transplant; Vaccination

Indexed keywords

CHICKENPOX VACCINE; CYTOMEGALOVIRUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; LIVE VACCINE; PNEUMOCOCCUS VACCINE;

ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CHICKENPOX; CHRONIC KIDNEY DISEASE; CYTOMEGALOVIRUS INFECTION; DIALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG UTILIZATION; HEMODIALYSIS; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INFECTION COMPLICATION; INFLUENZA; INFLUENZA VACCINATION; KIDNEY FAILURE; MORBIDITY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REVACCINATION; STREPTOCOCCUS INFECTION; VACCINATION;

BACTERIAL INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; VACCINATION;

EID: 33745411899     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2006.04.007     Document Type: Article

References (67)

1. U.S. Renal Data System. USRDS 2005 Annual Data Report (2005), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. Khan S.S., Kazmi W.H., Abichandani R., et al. Health care utilization among patients with chronic kidney disease. Kidney Int 62 (2002) 229-236
3. Sarnak M.J., and Jaber B.L. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 120 (2001) 1883-1887
4. Johnson D.W., and Fleming S.J. The use of vaccines in renal failure. Clin Pharmacokinet 22 (1992) 434-446
5. Ribot S., Rothstein M., Goldblat M., et al. Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patients. Arch Intern Med 139 (1979) 178-180
6. Harnett J.D., Parfrey P.S., Kennedy M., et al. The long-term outcome of hepatitis B infection in hemodialysis patients. Am J Kidney Dis 11 (1988) 210-213
7. Kausz A., and Pahari D. The value of vaccination in chronic kidney disease. Semin Dial 17 (2004) 9-11
8. Dinits-Pensy M., Forrest G.N., Cross A.S., et al. The use of vaccines in adult patients with renal disease. Am J Kidney Dis 46 (2005) 997-1011
9. Chatenoud L., Herbelin A., Beaurain G., et al. Immune deficiency of the uremic patient. Adv Nephrol Necker Hosp 19 (1990) 259-274
10. Beaman M., Michael J., MacLennan I.C., et al. T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Nephrol Dial Transplant 4 (1989) 216-221
11. Fuchshuber A., Kuhnemund O., Keuth B., et al. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 11 (1996) 468-473
12. Kasiske B.L., Cangro C.B., Hariharan S., et al. The evaluation of renal transplantation candidates. Clinical practice guidelines. Am J Transplant 1 suppl 2 (2002) 1-95
13. Recommended Adult Immunization Schedule-United States, October 2005-September 2006. MMWR Morb Mortal Wkly Rep 54 (2005) Q1-Q4
14. Robinson J. Efficacy of pneumococcal immunization in patients with renal disease-What is the data?. Am J Nephrol 24 (2004) 402-409
15. Cosio F.G., Giebink G.S., Le C.T., et al. Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients. Kidney Int 20 (1981) 254-258
16. Nikoskelainen J., Koskela M., Forsstrom J., et al. Persistence of antibodies to pneumococcal vaccine in patients with chronic renal failure. Kidney Int 28 (1985) 672-677
17. Linnemann Jr. C.C., First M.R., and Schiffman G. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med 146 (1986) 1554-1556
18. DaRoza G., Loewen A., Djurdjev O., et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization. Earlier is better. Am J Kidney Dis 42 (2003) 1184-1192
19. Buti M., Viladomiu L., Jardi R., et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 12 (1992) 144-147
20. Elwell R.J., Neumann M., and Bailie G.R. Factors associated with long-term antibody production induced by hepatitis B vaccine in patients undergoing hemodialysis. A retrospective cohort study. Pharmacotherapy 23 (2003) 1558-1563
21. Watkins S.L., Alexander S.R., Brewer E.D., et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 40 (2002) 365-372
22. Liu Y.L., Kao M.T., and Huang C.C. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 23 (2005) 3957-3960
23. McNulty C.A., Bowen J.K., and Williams A.J. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules. Vaccine 23 (2005) 4142-4147
24. Fleming S.J., Moran D.M., Cooksley W.G., et al. Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 22 (1991) 251-257
25. Jadoul M., and Goubau P. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients?. Clin Nephrol 58 (2002) 301-304
26. Navarro J.F., Teruel J.L., Mateos M.L., et al. Antibody level after hepatitis B vaccination in hemodialysis patients. Influence of hepatitis C virus infection. Am J Nephrol 16 (1996) 95-97
27. Peces R., de la Torre M., Alcazar R., et al. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 29 (1997) 239-245
28. Cheng C.H., Huang C.C., Leu M.L., et al. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine 15 (1997) 1353-1357
29. Ahuja T.S., Kumar S., Mansoury H., et al. Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis. Kidney Int 67 (2005) 1136-1141
30. Marangi A.L., Giordano R., Montanaro A., et al. Hepatitis B virus infection in chronic uremia. Long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis 23 (1994) 537-542
31. Vlassopoulos D. Recombinant hepatitis B vaccination in renal failure patients. Curr Pharm Biotechnol 4 (2003) 141-151
32. Peces R., and Laures A.S. Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine. Role of a booster dose on antibody response. Nephron 89 (2001) 172-176
33. Charest A.F., McDougall J., and Goldstein M.B. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36 (2000) 976-982
34. Fabrizi F., Andrulli S., Bacchini G., et al. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients. A prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 12 (1997) 1204-1211
35. Vlassopoulos D.A., Arvanitis D.K., Lilis D.S., et al. Lower long-term efficiency of intradermal hepatitis B vaccine compared to the intramuscular route in hemodialysis patients. Int J Artif Organs 22 (1999) 739-743
36. Seaworth B., Drucker J., Starling J., et al. Hepatitis B vaccines in patients with chronic renal failure before dialysis. J Infect Dis 157 (1988) 332-337
37. Oddone E.Z., Cowper P.A., Hamilton J.D., et al. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. Health Serv Res 28 (1993) 97-121
38. Antonen J.A., Hannula P.M., Pyhala R., et al. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 86 (2000) 56-61
39. Cavdar C., Sayan M., Sifil A., et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 37 (2003) 71-76
40. Robertson S., Newbigging K., Carman W., et al. Fulminating varicella despite prophylactic immune globulin and intravenous acyclovir in a renal transplant recipient. Should renal patients be vaccinated against VZV before transplantation?. Clin Transplant 20 (2006) 136-138
41. Fehr T., Bossart W., Wahl C., et al. Disseminated varicella infection in adult renal allograft recipients. Four cases and a review of the literature. Transplantation 73 (2002) 608-611
42. Rawson H., Crampin A., and Noah N. Deaths from chickenpox in England and Wales 1995-7. Analysis of routine mortality data. BMJ 323 (2001) 1091-1093
43. Geel A., Zuidema W., van Gelder T., et al. Successful vaccination against varicella zoster virus prior to kidney transplantation. Transplant Proc 37 (2005) 952-953
44. Chaves T.S., Lopes M.H., de Souza V.A., et al. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr Transplant 9 (2005) 192-196
45. Furth S.L., Hogg R.J., Tarver J., et al., Southwest Pediatric Nephrology Study Group. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 18 (2003) 33-38
46. Furth S.L., Arbus G.S., Hogg R., et al. Varicella vaccination in children with nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. J Pediatr 142 (2003) 145-148
47. Hedlund J., Christenson B., Lundbergh P., et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people. A 1-year follow-up. Vaccine 21 (2003) 3906-3911
48. Sisk J.E., Whang W., Butler J.C., et al. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age. Role of comorbid conditions and race. Ann Intern Med 138 (2003) 960-968
49. Fiebach N., and Beckett W. Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines. Arch Intern Med 154 (1994) 2545-2557
50. Gross P.A., Hermogenes A.W., Sacks H.S., et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 123 (1995) 518-527
51. Mahoney F.J., Stewart K., Hu H., et al. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 157 (1997) 2601-2605
52. Gilbertson D.T., Unruh M., McBean A.M., et al. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63 (2003) 738-743
53. Tokars J.I., Finelli L., Alter M.J., et al. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 17 (2004) 310-319
54. Kazancioglu R., Sever M.S., Yuksel-Onel D., et al. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin Transplant 14 (2000) 61-65
55. Recommendation for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 50 (2001) 1-43
56. Miller E.R., Alter M.J., and Tokars J.I. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 33 (1999) 356-360
57. Broyer M., Tete M.J., Guest G., et al. Varicella and zoster in children after kidney transplantation. Long-term results of vaccination. Pediatrics 99 (1997) 35-39
58. Olson A.D., Shope T.C., and Flynn J.T. Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation. Pediatr Transplant 5 (2001) 44-50
59. Plotkin S.A., Starr S.E., Friedman H.M., et al. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med 114 (1991) 525-531
60. Poole-Warren L.A., Hallett M.D., Hone P.W., et al. Vaccination for prevention of CAPD associated staphylococcal infection. Results of a prospective multicentre clinical trial. Clin Nephrol 35 (1991) 198-206
61. Shinefield H., Black S., Fattom A., et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 346 (2002) 491-496
62. Fleischmann E.H., Kruppenbacher J., Bock H.L., et al. Active immunization against hepatitis A in dialysis patients. Nephrol Dial Transplant 17 (2002) 1825-1828
63. Kausz A.T., Guo H., Pereira B.J., et al. General medical care among patients with chronic kidney disease. Opportunities for improving outcomes. J Am Soc Nephrol 16 (2005) 3092-3101
64. Fletcher T.J., Tunnicliffe W.S., Hammond K., et al. Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease. BMJ 314 (1997) 1663-1665
65. Dunn M.K., Misra S., Habermann R., et al. Pneumococcal vaccination in nursing homes. Does policy change practice?. J Am Med Dir Assoc 4 (2003) 135-138
66. Brown J., and Peters V. Improved hepatitis B vaccination rates in ESRD patients in California. Adv Ren Replace Ther 7 (2000) S95-S99
67. Willis B.C., Ndiaye S.M., Hopkins D.P., et al. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk. A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 54 (2005) 1-11